RioGin Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

RioGin General Information

Description

Developer of peptide therapeutic drugs designed to improve the pharmacokinetic properties of the drugs without negatively impacting their pharmacodynamic properties. The company's peptide therapeutic drugs use their proprietary platform technology to improve the patient's quality of life through convenient dosing and reduced side effects, resulting in better compliance, enabling patients to have better treatment at a low dosage without fearing adverse side effects.

Contact Information

Website
www.riogin.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Emerging Technology Center One, Suite 212
  • 1670 Discovery Drive
  • Charlottesville, VA 22911
  • United States
+1 (540)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Emerging Technology Center One, Suite 212
  • 1670 Discovery Drive
  • Charlottesville, VA 22911
  • United States
+1 (540)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RioGin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2016 Completed Out of Business
2. Grant 01-Jun-2015 Completed Startup
1. Early Stage VC 16-Apr-2014 $125K $125K Completed Startup
To view RioGin’s complete valuation and funding history, request access »

RioGin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of peptide therapeutic drugs designed to improve the pharmacokinetic properties of the drugs without negativel
Drug Discovery
Charlottesville, VA

Seattle, WA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RioGin Competitors (5)

One of RioGin’s 5 competitors is CTI BioPharma, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CTI BioPharma Formerly VC-backed Seattle, WA
Lite Strategy Corporation San Diego, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
ConjuChem Formerly VC-backed Montreal, Canada
Revive Therapeutics Corporation Toronto, Canada
You’re viewing 5 of 5 competitors. Get the full list »

RioGin Patents

RioGin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9273092-B2 Selective binding compounds Inactive 23-Dec-2011

RioGin FAQs

  • When was RioGin founded?

    RioGin was founded in 2013.

  • Where is RioGin headquartered?

    RioGin is headquartered in Charlottesville, VA.

  • What industry is RioGin in?

    RioGin’s primary industry is Drug Discovery.

  • Is RioGin a private or public company?

    RioGin is a Private company.

  • What is RioGin’s current revenue?

    The current revenue for RioGin is .

  • How much funding has RioGin raised over time?

    RioGin has raised $125K.

  • Who are RioGin’s competitors?

    CTI BioPharma, Lite Strategy, Kite Pharma, ConjuChem, and Revive Therapeutics are competitors of RioGin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process